ENZYMATIC ACTIVATION OF CHEMICALS TO TOXIC METABOLITES

[1] SUICIDE ENZYME INACTIVATORS [J]. ACCOUNTS OF CHEMICAL RESEARCH, 1976, 9 (09) : 313 - 319

[2] THE MECHANISM OF REDUCTIVE DEHALOGENATION OF HALOTHANE BY LIVER CYTOCHROME-P450 [J]. BIOCHEMICAL PHARMACOLOGY, 1982, 31 (03) : 383 - 390

[3] ANIMAL MODELING OF HUMAN POLYMORPHIC DRUG OXIDATION - THE METABOLISM OF DEBRISOQUINE AND PHENACETIN IN RAT INBRED STRAINS [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (03) : 161 - 164

[4] Anders M., COMMUNICATION

[5] ANDERSON WK, 1982, CANCER RES, V42, P2168

[6] AOYAMA T, 1982, MICROSOMES DRUG OXID, P83

[7] AUGUSTO O, 1982, J BIOL CHEM, V257, P1288

[8] BARON J, 1981, J BIOL CHEM, V256, P5931

[9] Baron J, 1983, EXTRAHEPATIC DRUG ME, P73

[10] TISSUE-MEDIATED MUTAGENICITY OF VINYLIDENE CHLORIDE AND 2-CHLOROBUTADIENE IN SALMONELLA-TYPHIMURIUM [J]. NATURE, 1975, 255 (5510) : 641 - 643

[1] SUICIDE ENZYME INACTIVATORS [J]. ACCOUNTS OF CHEMICAL RESEARCH, 1976, 9 (09) : 313 - 319

[2] THE MECHANISM OF REDUCTIVE DEHALOGENATION OF HALOTHANE BY LIVER CYTOCHROME-P450 [J]. BIOCHEMICAL PHARMACOLOGY, 1982, 31 (03) : 383 - 390

[3] ANIMAL MODELING OF HUMAN POLYMORPHIC DRUG OXIDATION - THE METABOLISM OF DEBRISOQUINE AND PHENACETIN IN RAT INBRED STRAINS [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (03) : 161 - 164

[4] Anders M., COMMUNICATION

[5] ANDERSON WK, 1982, CANCER RES, V42, P2168

[6] AOYAMA T, 1982, MICROSOMES DRUG OXID, P83

[7] AUGUSTO O, 1982, J BIOL CHEM, V257, P1288

[8] BARON J, 1981, J BIOL CHEM, V256, P5931

[9] Baron J, 1983, EXTRAHEPATIC DRUG ME, P73

[10] TISSUE-MEDIATED MUTAGENICITY OF VINYLIDENE CHLORIDE AND 2-CHLOROBUTADIENE IN SALMONELLA-TYPHIMURIUM [J]. NATURE, 1975, 255 (5510) : 641 - 643